Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, May 2026 and Jun 2026.
- Largest single sale: $1.7M (20,000 shares) of Protagonist Therapeutics, Inc on Feb 6, 2026. Filing
- Last sale before this period: Oct 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Director | Aug 10, 2016 | Jun 25, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 23, 2026, Protagonist Therapeutics, Inc: sold 9,000 shares for $1.1M, under a disclosed plan; 9,000 shares acquired by exercising options. 1 filing: 1
- Jun 10, 2026, Protagonist Therapeutics, Inc: sold 9,000 shares for $969K, under a disclosed plan; 9,000 shares acquired by exercising options. 1 filing: 1
- May 29, 2026, Protagonist Therapeutics, Inc: sold 9,000 shares for $897K, under a disclosed plan; 9,000 shares acquired by exercising options. 1 filing: 1
- Feb 6, 2026, Protagonist Therapeutics, Inc: sold 20,000 shares for $1.7M, no plan disclosed; 20,000 shares acquired by exercising options. 1 filing: 1
- Jan 2, 2026, Protagonist Therapeutics, Inc: 2,695 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.